Here’s Why Analysts Are Positive On Prestige Consumer Healthcare Inc. (PBH)

According to TheFly, Susan Anderson from Canaccord trimmed the terms people connected Prestige Consumer Healthcare Inc. (NYSE:PBH) to $88 from $100, portion keeping a ‘Buy’ standing connected the stock, connected November 7. The steadfast noted that the institution delivered coagulated results; however, absorption claims that income and net outperformed expectations owed to Clear Eyes proviso timing and the timing of circumstantial retailer orders, which volition trim the numbers for the 3rd quarter.

pikselstock/Shutterstock.com

In the second-quarter results announced connected November 6, Prestige Consumer Healthcare Inc. (NYSE:PBH) experienced a 6.1% diminution successful North American conception revenues, which was offset by a 2.5% emergence successful planetary conception revenues. The institution remained focused connected merchandise innovation and e-commerce strategies, absorption revealed successful the net call.

Prestige Consumer Healthcare Inc. (NYSE:PBH) is simply a New York-based supplier of over-the-counter (OTC) wellness and idiosyncratic attraction products. Incorporated successful 1996, the institution operates done 2 segments: North American OTC Healthcare and International OTC Healthcare.

While we admit the imaginable of PBH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.